Cargando…
Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue
Over the past two decades, cancer treatment has benefited from having a significant increase in the number of targeted drugs approved by the United States Food and Drug Administration. With the introduction of targeted therapy, a great shift towards a new era has taken place that is characterized by...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259985/ https://www.ncbi.nlm.nih.gov/pubmed/35814399 http://dx.doi.org/10.3389/fonc.2022.877380 |